BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23732262)

  • 1. Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes.
    Khoo CM; Chen J; Pamuklar Z; Torquati A
    Ann Surg; 2014 Mar; 259(3):494-501. PubMed ID: 23732262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
    Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.
    Salinari S; Bertuzzi A; Guidone C; Previti E; Rubino F; Mingrone G
    Ann Surg; 2013 Mar; 257(3):462-8. PubMed ID: 23388352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes.
    Omotosho P; Mor A; Shantavasinkul PC; Corsino L; Torquati A
    Surg Endosc; 2016 Jul; 30(7):2857-64. PubMed ID: 26823053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 Diabetes.
    Tangalakis LL; Tabone L; Spagnoli A; Muehlbauer M; Omotosho P; Torquati A
    Obes Surg; 2020 Jan; 30(1):290-295. PubMed ID: 31471767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Reduction of Visceral Adipose Tissue after Roux-en-Y Gastric Bypass Is more Pronounced in Patients with Impaired Glucose Metabolism.
    Favre L; Marino L; Roth A; Acierno J; Hans D; Demartines N; Pitteloud N; Suter M; Collet TH
    Obes Surg; 2018 Dec; 28(12):4006-4013. PubMed ID: 30109666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
    Malin SK; Samat A; Wolski K; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Int J Obes (Lond); 2014 Mar; 38(3):364-70. PubMed ID: 24166065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery.
    Polyzogopoulou EV; Kalfarentzos F; Vagenakis AG; Alexandrides TK
    Diabetes; 2003 May; 52(5):1098-103. PubMed ID: 12716738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss.
    Plum L; Ahmed L; Febres G; Bessler M; Inabnet W; Kunreuther E; McMahon DJ; Korner J
    Obesity (Silver Spring); 2011 Nov; 19(11):2149-57. PubMed ID: 21593800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.
    Morínigo R; Lacy AM; Casamitjana R; Delgado S; Gomis R; Vidal J
    Obes Surg; 2006 Dec; 16(12):1594-601. PubMed ID: 17217635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.
    Liaskos C; Koliaki C; Alexiadou K; Argyrakopoulou G; Tentolouris N; Diamantis T; Alexandrou A; Katsilambros N; Kokkinos A
    Obes Surg; 2018 Dec; 28(12):3997-4005. PubMed ID: 30112599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.
    Nosso G; Griffo E; Cotugno M; Saldalamacchia G; Lupoli R; Pacini G; Riccardi G; Angrisani L; Capaldo B
    Horm Metab Res; 2016 May; 48(5):312-7. PubMed ID: 26788926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass.
    Lin E; Davis SS; Srinivasan J; Sweeney JF; Ziegler TR; Phillips L; Gletsu-Miller N
    Am Surg; 2009 Jun; 75(6):498-502; discussion 502-3. PubMed ID: 19545098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids.
    Albaugh VL; Flynn CR; Cai S; Xiao Y; Tamboli RA; Abumrad NN
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1225-33. PubMed ID: 26196952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.
    Reed MA; Pories WJ; Chapman W; Pender J; Bowden R; Barakat H; Gavin TP; Green T; Tapscott E; Zheng D; Shankley N; Yieh L; Polidori D; Piccoli SP; Brenner-Gati L; Dohm GL
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2525-31. PubMed ID: 21593117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus.
    Soriguer F; Garrido-Sanchez L; Garcia-Serrano S; Garcia-Almeida JM; Garcia-Arnes J; Tinahones FJ; Garcia-Fuentes E
    Obes Surg; 2009 Nov; 19(11):1574-80. PubMed ID: 19756893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitivity is related to glycemic control in type 2 diabetes and diabetes remission after Roux-en Y gastric bypass.
    Gavin TP; Ernst JM; Caudill SE; Dohm GL; Pories WJ; Dar M; Reed MA
    Surgery; 2014 Jun; 155(6):1036-43. PubMed ID: 24856123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.
    Romero F; Nicolau J; Flores L; Casamitjana R; Ibarzabal A; Lacy A; Vidal J
    Surg Endosc; 2012 Aug; 26(8):2231-9. PubMed ID: 22302537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.